This article summarizes the available evidence reporting the relationship between perinatal dysglycemia and long-term neurodevelopment. We review the physiology of perinatal glucose metabolism and discuss the controversies surrounding definitions of perinatal dysglycemia. We briefly review the epidemiology of hypoglycemia and hyperglycemia in fetal, preterm, and term infants. We discuss potential pathophysiologic mechanisms contributing to dysglycemia and its effect on neurodevelopment. We highlight current strategies to prevent and treat dysglycemia in the context of neurodevelopmental outcomes. Finally, we discuss areas of future research and the potential role of continuous glucose monitoring.
Bibliographical noteFunding Information:
Dr M.E. Paulsen was supported by the National Institute of Health Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) grant K12HD055887 .
Dr M.E. Paulsen was supported by the National Institute of Health Building Interdisciplinary Research Careers in Women's Health (BIRCWH) grant K12HD055887.
- Blood glucose
- Hypoxic-ischemic encephalopathy
PubMed: MeSH publication types
- Journal Article
- Research Support, N.I.H., Extramural